Cargando…

Developing a definition of immune exclusion in cancer: results of a modified Delphi workshop

Checkpoint inhibitors represent an effective treatment approach for a variety of cancers through their inhibition of immune regulatory pathways within the tumor microenvironment (TME). Unfortunately only a minority of patients with cancer achieve clinical benefit from immunotherapy, with the TME eme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clifton, Guy Travis, Rothenberg, Mace, Ascierto, Paolo Antonio, Begley, Glenn, Cecchini, Michael, Eder, Joseph Paul, Ghiringhelli, Francois, Italiano, Antoine, Kochetkova, Marina, Li, Rong, Mechta-Grigoriou, Fatima, Pai, Sara I, Provenzano, Paolo, Puré, Ellen, Ribas, Antoni, Schalper, Kurt A, Fridman, Wolf Herve
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Position Article and Guidelines
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254706/ https://www.ncbi.nlm.nih.gov/pubmed/37290925 http://dx.doi.org/10.1136/jitc-2023-006773

Ejemplares similares

Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel
por: Spada, Francesca, et al.
Publicado: (2022)

Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspective
por: Quinn, Casey, et al.
Publicado: (2020)

Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with targeted therapies
por: Atkins, Michael B, et al.
Publicado: (2023)

The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response
por: Arnaldez, Fernanda I, et al.
Publicado: (2020)

Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data
por: Reynolds, Kerry L, et al.
Publicado: (2021)

Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC)
por: Atkins, Michael B, et al.
Publicado: (2022)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
por: Brahmer, Julie R, et al.
Publicado: (2021)

Telemedicine monitoring in the follow-up of kidney transplant recipients: consensus indications from an Italian panel of surgeons and nephrologists after the COVID-19 experience
por: Biancone, Luigi, et al.
Publicado: (2022)

The Society for Immunotherapy in Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation
por: Taube, Janis M, et al.
Publicado: (2020)

Real-World Experience of Methotrexate in the Treatment of Skin Diseases: an Italian Delphi Consensus
por: Damiani, Giovanni, et al.
Publicado: (2023)

Position paper on the safety/efficacy profile of Direct Oral Anticoagulants in patients with Chronic Kidney Disease: Consensus document of Società Italiana di Nefrologia (SIN), Federazione Centri per la diagnosi della trombosi e la Sorveglianza delle terapie Antitrombotiche (FCSA) and Società Italiana per lo Studio dell’Emostasi e della Trombosi (SISET)
por: Grandone, Elvira, et al.
Publicado: (2020)

Recommendations for standardizing biopsy acquisition and histological assessment of immune checkpoint inhibitor-associated colitis
por: Ma, Christopher, et al.
Publicado: (2022)

Defining current gaps in quality measures for cancer immunotherapy: consensus report from the Society for Immunotherapy of Cancer (SITC) 2019 Quality Summit
por: Pai, Sara, et al.
Publicado: (2020)

COVID-19 and kidney transplantation: an Italian Survey and Consensus
por: Vistoli, Fabio, et al.
Publicado: (2020)

Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce
por: Kluger, Harriet M., et al.
Publicado: (2020)

Canadian hereditary angioedema guideline
por: Betschel, Stephen, et al.
Publicado: (2014)

World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Prebiotics
por: Cuello-Garcia, Carlos A., et al.
Publicado: (2016)

World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Vitamin D
por: Yepes-Nuñez, Juan José, et al.
Publicado: (2016)

NAVIGATOR: an Italian regional imaging biobank to promote precision medicine for oncologic patients
por: Borgheresi, Rita, et al.
Publicado: (2022)

Diagnostic tools in Rhinology EAACI position paper
por: Scadding, Glenis, et al.
Publicado: (2011)

Hemoglobin A1c measurement for the diagnosis of Type 2 diabetes in children
por: Kapadia, Chirag, et al.
Publicado: (2012)

The biodiversity hypothesis and allergic disease: world allergy organization position statement
por: Haahtela, Tari, et al.
Publicado: (2013)

Predictive, Preventive and Personalised Medicine as the hardcore of ‘Horizon 2020’: EPMA position paper
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

Towards personal health care with model-guided medicine: long-term PPPM-related strategies and realisation opportunities within ‘Horizon 2020’
por: Lemke, Heinz U, et al.
Publicado: (2014)

EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy
por: Calderon, Moises A, et al.
Publicado: (2012)

Research needs in allergy: an EAACI position paper, in collaboration with EFA
por: Papadopoulos, Nikolaos G, et al.
Publicado: (2012)

Fungal allergy in asthma–state of the art and research needs
por: Denning, David W, et al.
Publicado: (2014)

EPMA summit 2014 under the auspices of the presidency of Italy in the EU: professional statements
por: Golubnitschaja, Olga, et al.
Publicado: (2015)

EPMA position paper in cancer: current overview and future perspectives
por: Grech, Godfrey, et al.
Publicado: (2015)

Dietary exposures and allergy prevention in high-risk infants: a joint position statement of the Canadian Society of Allergy and Clinical Immunology and the Canadian Paediatric Society
por: Chan, Edmond S, et al.
Publicado: (2014)

Predicting formation of adhesions after gynaecological surgery: development of a risk score
por: Lundorff, Per, et al.
Publicado: (2015)

Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants
por: Fleischer, David M., et al.
Publicado: (2015)

World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics
por: Fiocchi, Alessandro, et al.
Publicado: (2015)

CSACI position statement: systemic effect of inhaled corticosteroids on adrenal suppression in the management of pediatric asthma
por: Issa-El-Khoury, Karine, et al.
Publicado: (2015)

Allergen immunotherapy on the way to product-based evaluation—a WAO statement
por: Bachert, Claus, et al.
Publicado: (2015)

2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines
por: Simons, F. Estelle R., et al.
Publicado: (2015)

Expert consensus on standardized diagnosis and treatment for heat stroke
Publicado: (2016)

Addendum guidelines for the prevention of peanut allergy in the United States: report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel
por: Togias, Alkis, et al.
Publicado: (2017)

Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–sponsored expert panel
por: Togias, Alkis, et al.
Publicado: (2017)

Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA(2)LEN)
por: Braido, F., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_h86673jn5uub4eofvqqh4ep48h